Studies on Adsorption International Learning Initiative Global
Recruiting · NCT07123909 · Interventional (participants receive a specific treatment) · Lead sponsor: Botkin Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Patients will undergo a combined hemodialysis and hemosorption procedure. The study cartridge for hemosorption by Jafron HA130 contains the original adsorbing material.
What this trial is about
Use of sorption technologies in patients undergoing maintenance hemodialysis with inflammatory syndrome and clinical manifestations of uremia
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Adequate dialysis defined by a KT/V index ≥ 1.4
- No active inflammatory process or infection
- Age ≥ 18 years
- Receiving standard hemodialysis regimen three times weekly, at least 4 hours per session
- Participants with elevated interleukin-6 (IL-6) and/or C-reactive protein (CRP) levels exceeding local laboratory reference values
Exclusion criteria
- Current use of steroids or immunosuppressive therapy
- History of kidney transplantation
- Diagnosis of cancer
- Pregnancy
Where it is running
1 location listed.
- Botkin Hospital - Moscow, Russia